Stockscreener 앱 받기
1.815
6.14%
0.105
Microbot Medical Inc 주식(MBOT)의 최신 뉴스
Microbot Medical receives Israel approval for robotic system By Investing.com - Investing.com Canada
Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System - The Manila Times
[8-K] Microbot Medical Inc. Reports Material Event - Stock Titan
Israel clears single-use LIBERTY vascular robot, opening new markets - Stock Titan
After plunging 22.6% in 4 weeks, here's why the trend might reverse for Microbot Medical (MBOT) - MSN
After Plunging 22.6% in 4 Weeks, Here's Why the Trend Might Reverse for Microbot Medical (MBOT) - Yahoo Finance
Microbot Medical Inc stock (US5950101098): Liberty launch drives first-quarter revenue and raises in - AD HOC NEWS
Microbot Medical Inc. (MBOT) reports Q1 loss, misses revenue estimates - MSN
Microbot Medical stock (US5950101098): Cash runway, pipeline, and what investors are watching - AD HOC NEWS
Microbot Medical (NASDAQ:MBOT) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Microbot Medical Inc stock (US5950101098): LIBERTY call and Q1 2026 numbers keep focus on robot-assi - AD HOC NEWS
Microbot Medical Schedules Call on LIBERTY System Progress - TipRanks
Microbot Medical to Host May 18 Call Addressing LIBERTY FMR Progress and Third‑Party Article - TradingView
Microbot Medical (NASDAQ: MBOT) sets investor call on LIBERTY progress and recent article - Stock Titan
Microbot Medical to host call addressing recent claims and progress of LIBERTY robotic system - Pluang
Microbot Medical Inc. to Host Conference Call Addressing Misrepresentations from Unaffiliated Third-Party Article - Quiver Quantitative
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu - The Manila Times
Doctors using Microbot’s LIBERTY robot to address article claims - Stock Titan
Microbot Medical (MBOT) Reports Q1 Loss and Faces Short Seller S - GuruFocus
Microbot Medical (MBOT) Faces Stock Plunge Amid Short Seller Rep - GuruFocus
Microbot Medical Inc stock (US5950101098): shares under pressure after short-seller report and weak - AD HOC NEWS
Microbot Medical plunges amid results, short report from White Diamond Research - MSN
Microbot Medical Reports First Revenue from LIBERTY System as Commercial Adoption Accelerates Across U.S. Hospitals 1 - Minichart
Microbot Medical stock drops after White Diamond short report By Investing.com - Investing.com Australia
Microbot Medical stock drops after White Diamond short report - Investing.com
Microbot Medical Launches Full Commercial LIBERTY System Rollout - TipRanks
Microbot Medical Q2 revenue surpasses Q1 after system launch - Investing.com
Microbot Medical Q2 revenue surpasses Q1 after system launch By Investing.com - Investing.com Australia
Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System - TradingView
Microbot Medical records Q1 revenue; Q2 mid-quarter revenue already exceeds Q1 as LIBERTY adoption grows - TradingView
Microbot Medical (NASDAQ: MBOT) sees LIBERTY system revenue rise in Q2 - Stock Titan
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026 - GlobeNewswire
Microbot Medical Inc. (MBOT) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Microbot Medical Inc. (MBOT) latest stock news and headlines - Yahoo Finance Singapore
Microbot Medical Inc. 1Q 2026: Revenue $105K, Net income $(3.67M) — 10-Q Summary - TradingView
Microbot Medical (NASDAQ: MBOT) starts LIBERTY robot sales with strong cash - Stock Titan
Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MBOT Stock Price, Quote & Chart | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
TradingKey - TradingKey
MSN Money - MSN
Number of shareholders of Microbot Medical Inc. – NASDAQ:MBOT - TradingView
Microbot Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - MarketBeat
Microbot Medical’s LIBERTY System Gains Early Market Traction - TipRanks
Microbot Medical®'s Liberty® endovascular robotic system is now adopted by multiple accounts across key territories including two Access-PVI pivotal clinical trial sites - marketscreener.com
A blood-vessel robot lands 2 trial sites as its rollout expands - Stock Titan
Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites - TradingView
Microbot wins multiple LIBERTY system accounts, including two ACCESS-PVI trial sites - TradingView
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites - marketscreener.com
Microbot Medical (MBOT) gains new LIBERTY robotic adopters post-SIR - Stock Titan
Microbot Medical (NASDAQ:MBOT) Cut to "Strong Sell" at Wall Street Zen - MarketBeat
Microbot Medical Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia - marketscreener.com
1.16%
0.04%
자본화:
|
볼륨(24시간):